abstract |
(57) [Summary] For example, the formula (I) Having the structure XYZAB wherein X is a 5-, 6- or 7-membered aromatic or non-aromatic ring, and Y is a 5- or 6-membered aromatic ring Receptor antagonists and their pharmaceutically acceptable salts. |